The SEAFARER project enables clinical radiation therapy departments to assess the performance of their Patient Specific Quality Assurance (PSQA) process.
PSQA, alongside other quality assurance measures, plays an important role in delivering safe radiation therapy. PSQA tends to be resource intensive, and it has been shown to not always identify problems with treatment plans (Kry et al 2014).
Through simulation of realistic and clinically relevant treatment delivery errors, the SEAFARER project allows departments to test the sensitivity of their PSQA process. Following a successful international pilot for a stereotactic spine case (Lehmann et al 2022) the project is now being upgraded and expanded to other treatment sites.
To register your interest, complete the expression of interest survey.
Trans Tasman Radiation Oncology Group (TROG) & National Physical Laboratory, UK (NPL)
Prof Peter Greer, Calvary Mater Newcastle, NSW
Prof Joerg Lehmann, Calvary Mater Newcastle, NSW
Clinical Trial Registration
The journey to becoming the 200th participant for the
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292